SPEAC has been hard at work ensuring patients have access to the treatments that are recommended by their physicians through the oral chemotherapy parity legislation around the country. We’re thrilled to inform you that twenty-six states and the District of Columbia have passed these critical laws to increase access to oral oncology drugs that are crucial to patient survival. In order to help patients get the most out of these laws we have created a fact sheet to inform you and your clinicians on the specifics of the law and how to help patients in your state contact the correct authorities if their insurance company is not in compliance with the law.

We need YOUR help to get this information to community oncologists! Please print a copy of your state fact sheet to take with you to your next visit with your clinician. Click on your state below to download the fact sheet. The new laws apply to all oral anti-cancer medications, so they will be helpful for every oncologists.

If you have any questions, please contact SPEAC at speac@myeloma.org.

THANK YOU for helping us spread the word!

3 Responses to Oral Chemo Access Map

  1. Kris Cassar says:

    Do you know of any thing going on in Michigan on the oral chemo issue?

  2. Meghan Buzby, International Myeloma Foundation says:

    Hi Kris,

    Michigan had a bill introduced last session that unfortunately died. Right now, groups in Michigan are having conversations about next steps for 2015.

  3. My name is Thomas P Gleason. I have been taking THALIDOMIDE (THALOMID) for over 12 years. The
    cost of this DRUG has escalated to 23,511.27 a month. When I started on the drug the cost was 1800.a
    month. I am with Aetna through Medicare. I use two Foundations to help with the co-pay (1237.44) a
    month. The cost of this Drug is beyond absurd; it was given to Women in the fifties for morning sickness.
    What is going on to get the cost of this drug down. How can the FDA allow this drug to escalate like this. I
    and many others Im’ sure are wondering the same thing.

    Thank You
    Thomas P Gleason

Leave a Reply